VALGANCICLOVIR HYDROCHLORIDE
| Brand name | VALCYTE |
|---|---|
| Active ingredient | VALGANCICLOVIR HYDROCHLORIDE |
| Strength | 50MG/ML |
| Dosage form | FOR SOLUTION |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | August 2009 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 9642911 | December 2027 | product |
| 8889109 | December 2027 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.